Authors:
KUMAR ML
JOHNSON CE
CHUI LW
WHITWELL JK
STAEHLE B
NALIN D
Citation: Ml. Kumar et al., IMMUNE-RESPONSE TO MEASLES-VACCINE IN 6-MONTH-OLD INFANTS OF MEASLES SERONEGATIVE MOTHERS, Vaccine, 16(20), 1998, pp. 2047-2051
Authors:
BERTINO JS
THOELEN S
VANDAMME P
BRYAN JP
BECHERER PR
FREY S
HAYDEN FG
MARCUS LC
PARENTI DM
SPERLING M
CHAN ISF
BROWN L
NALIN D
Citation: Js. Bertino et al., A DOSE-RESPONSE STUDY OF HEPATITIS-A VACCINE IN HEALTHY-ADULTS WHO ARE GREATER-THAN-OR-EQUAL-TO-30 YEARS OLD AND WEIGH GREATER-THAN-OR-EQUAL-TO-77 KG, The Journal of infectious diseases, 178(4), 1998, pp. 1181-1184
Authors:
REUMAN PD
KUBILIS P
HURNI W
BROWN L
NALIN D
Citation: Pd. Reuman et al., THE EFFECT OF AGE AND WEIGHT ON THE RESPONSE TO FORMALIN-INACTIVATED,ALUM-ADJUVANTED HEPATITIS-A VACCINE IN HEALTHY-ADULTS, Vaccine, 15(10), 1997, pp. 1157-1161
Authors:
LAUFER DS
HURNI W
WATSON B
MILLER W
RYAN J
NALIN D
BROWN L
Citation: Ds. Laufer et al., SALIVA AND SERUM AS DIAGNOSTIC MEDIA FOR ANTIBODY TO HEPATITIS-A VIRUS IN ADULTS AND IN INDIVIDUALS WHO HAVE RECEIVED AN INACTIVATED HEPATITIS-A VACCINE, Clinical infectious diseases, 20(4), 1995, pp. 868-871
Authors:
NEWCOMER W
RIVIN B
REID R
MOULTON LH
WOLFF M
CROLL J
JOHNSON C
BROWN L
NALIN D
SANTOSHAM M
Citation: W. Newcomer et al., IMMUNOGENICITY, SAFETY AND TOLERABILITY OF VARYING DOSES AND REGIMENSOF INACTIVATED HEPATITIS-A VIRUS-VACCINE IN NAVAJO CHILDREN, The Pediatric infectious disease journal, 13(7), 1994, pp. 640-642
Authors:
BLOCK SL
HEDRICK JA
TYLER RD
SMITH RA
CALANDRA G
PATTERSON C
LEWIS J
SITRIN R
MILLER W
SCHWARTZ S
WIENS B
NALIN D
Citation: Sl. Block et al., SAFETY, TOLERABILITY AND IMMUNOGENICITY OF A FORMALIN-INACTIVATED HEPATITIS-A VACCINE (VAQTA(R)) IN RURAL KENTUCKY CHILDREN, The Pediatric infectious disease journal, 12(12), 1993, pp. 976-980
Authors:
WERZBERGER A
KUTER B
SHOUVAL D
MENSCH B
BROWN L
WIENS B
LEWIS J
MILLER W
SITRIN R
PROVOST P
NALIN D
Citation: A. Werzberger et al., ANATOMY OF A TRIAL - A HISTORICAL VIEW OF THE MONROE INACTIVATED HEPATITIS A PROTECTIVE EFFICACY TRIAL, Journal of hepatology, 18, 1993, pp. 190000046-190000050
Authors:
SHAPIRO C
GREEN M
LEMON S",VANHATTUM,DESMYTER,"HOLLINGER B",TOUKAN,"NALIN D
SHOUVAL D
WERZBERGER A
PAPAEVANGELOU G
LEWIS J",JILG,LEWIS
Citation: C. Shapiro et al., INTERNATIONAL-SYMPOSIUM ON HEPATITIS-A VACCINE RHODES, GREECE, JUNE 10, 1992 .1. RATIONALE FOR AN INACTIVATED HEPATITIS-A VIRUS-VACCINE, Journal of hepatology, 18, 1993, pp. 190000065-190000071